论著

紫花前胡素在动脉粥样硬化中的抗炎作用及其药物安全性评估

  • 陈辉 ,
  • 杨玲 ,
  • 赵安琪 ,
  • 查晴 ,
  • 杨克 ,
  • 刘艳
展开
  • 1.上海交通大学医学院附属第九人民医院心血管内科,上海 200011
    2.上海交通大学医学院附属瑞金医院心血管内科,上海 200025
*:陈辉与杨玲为并列第一作者
刘 艳 E-mail:liuyan0321@sjtu.deu.cn

收稿日期: 2025-01-03

  网络出版日期: 2026-01-30

基金资助

国家自然科学基金项目(82070401)

版权

《内科理论与实践》编辑部, 2025, 版权所有,未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。

Anti-inflammatory effects and safety evaluation of decursin in atherosclerosis

  • CHEN Hui ,
  • YANG Ling ,
  • ZHAO Anqi ,
  • ZHA Qing ,
  • YANG Ke ,
  • LIU Yan
Expand
  • 1. Department of Cardiovascular Medicine, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China
    2. Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received date: 2025-01-03

  Online published: 2026-01-30

Copyright

, 2025, Copyright reserved © 2025.

摘要

目的:探讨紫花前胡素在动脉粥样硬化疾病中的抗炎作用及其安全性,并验证其对巨噬细胞炎症反应的调节作用。方法:构建高脂饮食喂养的载脂蛋白E基因敲除(apolipoprotein E deficient, ApoE-/-)雄性小鼠动脉粥样硬化模型,通过氧化型低密度脂蛋白(oxidized low-density lipoprotein, oxLDL)刺激RAW 264.7巨噬细胞以诱导泡沫细胞形成。采用油红O(oil red O, ORO)染色评估主动脉斑块面积减少比例。通过蛋白质印迹检测核因子κB(nuclear factor κB, NF-κB)的磷酸化水平,采用炎症因子阵列分析血清及细胞上清中炎症因子水平,并通过苏木精-伊红(hematoxylin-eosin, HE)染色评估紫花前胡素的全身毒性。结果:紫花前胡素显著减少主动脉斑块面积,在oxLDL刺激的巨噬细胞中,其可抑制NF-κB的过度活化,下调促炎因子[如白介素(interleukin, IL)-2和干扰素(interferon, IFN)-γ]的表达,同时上调抗炎因子(如IL-4和IL-10)的水平。此外,在ApoE-/-小鼠模型中,紫花前胡素同样显著降低了血清中促炎因子水平,提高抗炎因子水平。HE染色结果显示,紫花前胡素未对主要器官造成明显的病理损伤。结论:紫花前胡素通过调控巨噬细胞炎症反应发挥显著的抗炎作用,并减轻动脉粥样硬化病变,安全性较高,有望成为治疗动脉粥样硬化的潜在药物。

本文引用格式

陈辉 , 杨玲 , 赵安琪 , 查晴 , 杨克 , 刘艳 . 紫花前胡素在动脉粥样硬化中的抗炎作用及其药物安全性评估[J]. 内科理论与实践, 2026 , 20(06) : 457 -461 . DOI: 10.16138/j.1673-6087.2025.06.05

Abstract

Objective To investigate the anti-inflammatory effects and safety of decursin in atherosclerosis, and to verify its regulatory role in macrophage inflammatory responses. Methods An atherosclerosis model was established using apolipoprotein E deficient (ApoE-/-) male mice fed a high-fat diet. RAW 264.7 macrophages were stimulated with oxidized low-density lipoprotein (oxLDL) to induce foam cell formation. Oil Red O (ORO) staining was employed to measure the reduction in aortic plaque area. Western blotting was performed to detect the phosphorylation levels of nuclear factor-κB (NF-κB). Inflammatory cytokine levels in serum and cell supernatants were analyzed using inflammatory cytokine arrays. Systemic toxicity of decursin was assessed by hematoxylin-eosin (HE) staining. Results Decursin significantly reduced aortic plaque area and inhibited the excessive activation of NF-κB in oxLDL-stimulated macrophages. It downregulated the expression of pro-inflammatory cytokines [interleukin (IL)-2 and interferon (IFN)-γ] while upregulating anti-inflammatory cytokines (IL-4 and IL-10). Furthermore, in the ApoE-/- mouse model, decursin similarly significantly lowered serum levels of pro-inflammatory cytokines and elevated those of anti-inflammatory cytokines. HE staining results showed that decursin caused no obvious pathological damage to major organs.Conclusions Decursin exerts significant anti-inflammatory effects by regulating macrophage inflammatory responses, alleviates atherosclerotic lesions, and demonstrates a high safety profile, suggesting its potential as a therapeutic agent for atherosclerosis.

参考文献

[1] Lusis AJ. Atherosclerosis[J]. Nature, 2000, 407(6801):233-241.
[2] Glass CK, Witztum JL. Atherosclerosis. the road ahead [J]. Cell, 2001, 104(4):503-516.
[3] Kockx MM, Herman AG. Apoptosis in atherosclerosis: beneficial or detrimental?[J]. Cardiovasc Res, 2000, 45(3):736-746.
[4] Mestas J, Ley K. Monocyte-endothelial cell interactions in the development of atherosclerosis[J]. Trends Cardiovasc Med, 2008, 18(6):228-232.
[5] Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis[J]. Cell, 2011, 145(3):341-355.
[6] Doran AC, Yurdagul A Jr, Tabas I. Efferocytosis in health and disease[J]. Nat Rev Immunol, 2020, 20(4):254-267.
[7] Kasikara C, Doran AC, Cai B, et al. The role of non-resolving inflammation in atherosclerosis[J]. J Clin Invest, 2018, 128(7):2713-2723.
[8] Yurdagul A Jr, Doran AC, Cai B, et al. Mechanisms and consequences of defective efferocytosis in atherosclerosis[J]. Front Cardiovasc Med, 2018, 4: 86.
[9] Bank S, Andersen PS, Burisch J, et al. Polymorphisms in the toll-like receptor and the IL-23/IL-17 pathways were associated with susceptibility to inflammatory bowel disease in a Danish cohort[J]. PLoS One, 2015, 10(12):e0145302.
[10] Jiang C, Lee HJ, Li GX, et al. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer[J]. Cancer Res, 2006, 66(1):453-463.
[11] Kim JH, Jeong JH, Jeon ST, et al. Decursin inhibits induction of inflammatory mediators by blocking nuclear factor-kappaB activation in macrophages[J]. Mol Pharmacol, 2006, 69(6):1783-1790.
[12] Kim WJ, Lee MY, Kim JH, et al. Decursinol angelate blocks transmigration and inflammatory activation of cancer cells through inhibition of PI3K, ERK and NF-kappaB activation[J]. Cancer Lett, 2010, 296(1):35-42.
[13] Islam SU, Lee JH, Shehzad A, et al. Decursinol angelate inhibits LPS-induced macrophage polarization through modulation of the NFκB and MAPK signaling pathways[J]. Molecules, 2018, 23(8):1880.
[14] National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the care and use of laboratory animals, 8th edition [EB/OL]. 2011. https://www.ncbi.nlm.nih.gov/books/NBK54050/.
文章导航

/